<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id><journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id><journal-id journal-id-type="pmc-domain-id">928</journal-id><journal-id journal-id-type="pmc-domain">capmc</journal-id><journal-title-group><journal-title>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</journal-title></journal-title-group><issn pub-type="ppub">0893-133X</issn><issn pub-type="epub">1740-634X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>PMC Canada Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5258186</article-id><article-id pub-id-type="pmcid-ver">PMC5258186.1</article-id><article-id pub-id-type="pmcaid">5258186</article-id><article-id pub-id-type="pmcaiid">5258186</article-id><article-id pub-id-type="manuscript-id">CAMS1180</article-id><article-id pub-id-type="pmid">18668033</article-id><article-id pub-id-type="doi">10.1038/npp.2008.110</article-id><article-id pub-id-type="manuscript-id-alternative">CAMS1180</article-id><article-id pub-id-type="manuscript-id-alternative">CAPMC1180</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Brain Drug-Metabolizing Cytochrome P450 Enzymes are Active <italic toggle="yes">In Vivo</italic>, Demonstrated by Mechanism-Based Enzyme Inhibition</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Miksys</surname><given-names initials="S">Sharon</given-names></name><xref rid="FN1" ref-type="author-notes">*</xref><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tyndale</surname><given-names initials="RF">Rachel F</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada</aff><aff id="A2">
<label>2</label>Department of Pharmacology, University of Toronto, Toronto, ON, Canada</aff><author-notes><corresp id="FN1"><label>*</label>Correspondence: Dr S Miksys, Department of Pharmacology, Rm 4334, University of Toronto, 1 King&#8217;s College Circle, Toronto, ON, Canada M5S 1A8, Tel: + 416 978 5155, Fax: + 416 978 6395, <email>s.miksys@utoronto.ca</email></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>7</month><year>2008</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2009</year></pub-date><volume>34</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">285372</issue-id><fpage>634</fpage><lpage>640</lpage><pub-history><event event-type="nihms-submitted"><date><day>18</day><month>11</month><year>2016</year></date></event><event event-type="pmc-release"><date><day>23</day><month>01</month><year>2017</year></date></event><event event-type="pmc-live"><date><day>23</day><month>01</month><year>2017</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-17 11:25:13.293"><day>17</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms1180.pdf"/><abstract><p id="P1">Individuals vary in their response to centrally acting drugs, and this is not always predicted by drug plasma levels. Central metabolism by brain cytochromes P450 (CYPs) may contribute to interindividual variation in response to drugs. Brain CYPs have unique regional and cell-type expression and induction patterns, and they are regulated independently of their hepatic isoforms. <italic toggle="yes">In vitro</italic>, these enzymes can metabolize endogenous and xenobiotic substrates including centrally acting drugs, but there is no evidence to date of their <italic toggle="yes">in vivo</italic> function. This has been difficult to demonstrate in the presence of hepatically derived metabolites that may cross the blood&#8211;brain barrier. In addition, because of the membrane location of brain CYPs and the rate limiting effect of endogenous heme levels on the activity and appropriate membrane insertion of some induced CYPs, it has been unclear whether sufficient cofactors and coenzymes are present for constitutive and induced CYP forms to be enzymatically active. We have developed a method using a radiolabeled mechanism-based inhibitor of CYP2B1, <sup>3</sup>H-8-methoxypsoralen, to demonstrate for the first time that both the constitutive and induced forms of this enzyme are active <italic toggle="yes">in situ</italic> in the living rat brain. This methodology provides a novel approach to assess the function of enzymes in extrahepatic tissues, where expression levels are often low. Selective induction of metabolically active drug metabolizing enzymes in the brain may also provide ways to control prodrug activation in specific brain regions as a novel therapeutic avenue.</p></abstract><kwd-group><kwd>cytochromes P450</kwd><kwd>brain</kwd><kwd>drug metabolism</kwd><kwd>mechanism-based inhibitor</kwd><kwd>nicotine</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>